BLOOMBERG Bloomberg Markets European Close July 11, 2024
Questions were raised over astrazeneca trial results. The ceo telling bloomberg within the last few minutes that it will now likely as a result run a new global trial, saying, now that we have found what looks like a better efficacy, we are going to have to validate this, and we need to do an additional study. It looks like it is going to be half of those full dose that could produce a higher efficacy then maybe a full dose. Europe and the United States continued to struggle with containing the virus resurgence. Germany is seeing a record increase in new cases, while new york cases are approac...